HIPK2 and non-small cell lung carcinoma: For instance, HIPK2 copy number gain was found to be associated with non-small cell lung cancer (NSCLC) cell lines through activation of the Yes-associated protein (YAP) pathway and subsequently increased tumour proliferation (Dai et al., 2021).